Clinical Trial Update: Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee [Phase 3]

View source ↗

Summary

A Phase 3, placebo-controlled trial of OROS Hydromorphone Hydrochloride for moderate-to-severe pain due to osteoarthritis of the hip or knee has completed and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• OROS Hydromorphone Hydrochloride (Hydromorphone hydrochloride)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Pain, Osteoarthritis, Hip | Phase 3 | Status: COMPLETED | Results posted: 2010-09-06